¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©
¼¶±ð: ²©Ê¿
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-20   

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© Wp(Rw4j  
~*hCTqH vN  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© <|1Khygv  
  1¡¢Co-stimulators (or co-stimulating molecules) C"R}_C|r)*  
  2¡¢NK-kB CG] /.  
  3¡¢Immunoglobulin superfamily 4a zqH;i  
  4¡¢antigen-presenting cell (APC) Sv t%*j  
  5¡¢death domain u-@;Q<v$  
  6¡¢CCR and CXCR ,*Wp$  
  7¡¢Lectin (or mitogen) />2zKF?  
  8¡¢Clusters of differentiation, CD) J6gn!  
  9¡¢B7 family ~WKWx.ul  
  10¡¢Cytotoxic T lymphocyte, CTL) ]e(\<R6Gf  
  11¡¢IL-15 and IL-15 receptor (IL-15R) w}0rDWuR[  
  12¡¢MHC restriction @ nOuFX4  
  13¡¢Affinity-chromatography ?G 'sb}.  
  14¡¢Cyctosprin A, CsA D*t[5,~ j  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) +Ou<-EQV  
gUH|?@f  
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© H^<?h6T  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 {hVc,\A  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ z[l_<`J$9  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ V\=%u<f  
N5 mhs#  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© g=jB'h?  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ?d_vD@+\  
  ѪҺ²¡Ñ§×¨Òµ£º &'u%|A@  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»